Evidence map›Paper›PMID 42368215›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2026

Contemporary evidence in protected percutaneous coronary intervention: a case-based review.

Ovidio De Filippo, Jürgen Leick, Giuseppe Tarantini, Ee Ling Heng, Guido Tavazzi, Roberto Lorusso, Assad Haneya, Nikos Werner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ovidio De FilippoDivision of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza (AOU), Corso Bramante 88/90, 10126 Turin, Italy.ORCID https://orcid.org/0000-0002-4915-9501
Jürgen LeickHeart Centre Trier, Hospital of the Brothers of Mercy, Nordallee 1, 54292 Trier, Germany.
Giuseppe TarantiniDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Interventional Cardiology Unit, 35121 Padova PD, Italy.
Ee Ling HengDepartment of Cardiology, Royal Brompton and Harefield Hospitals, Sydney Street, London SW3 6NP, UK.
Guido TavazziDepartment of Clinical-Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy.ORCID https://orcid.org/0000-0002-9560-5138
Roberto LorussoCardio-Thoracic Surgery Department, Maastricht University Medical Centre+, 6620 ER Maastricht, The Netherlands.ORCID https://orcid.org/0000-0002-1777-2045
Assad HaneyaHeart Centre Trier, Hospital of the Brothers of Mercy, Nordallee 1, 54292 Trier, Germany.
Nikos WernerHeart Centre Trier, Hospital of the Brothers of Mercy, Nordallee 1, 54292 Trier, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-risk percutaneous coronary intervention (PCI) in patients with markedly reduced left ventricular ejection fraction (LVEF) carries a substantial risk of haemodynamic collapse, creating an unmet need for strategies that allow complete, optimized revascularization without compromising safety. These cases often fall within the

Indexed as

Haemodynamic supportHigh-risk PCIIABPImpella CPLeft main diseaseMultivessel CADProtected PCIReduced LVEFVA-ECMO

Identifiers

PMID42368215
PMCPMC13294559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.